|1.||Sasaki, Hajime: 5 articles (08/2011 - 08/2004)|
|2.||Arai, Hidekazu: 5 articles (03/2010 - 08/2004)|
|3.||Takeda, Eiji: 4 articles (08/2007 - 08/2004)|
|4.||Taketani, Yutaka: 4 articles (08/2007 - 08/2004)|
|5.||Yamamoto, Hironori: 3 articles (08/2007 - 11/2005)|
|6.||Fukaya, Makiko: 3 articles (08/2007 - 08/2004)|
|7.||Doi, Toshio: 3 articles (08/2007 - 08/2004)|
|8.||Mizuno, Akira: 3 articles (08/2007 - 08/2004)|
|9.||Yamatsuji, Tomoki: 2 articles (03/2010 - 04/2007)|
|10.||Katayama, Hiroshi: 2 articles (03/2010 - 04/2007)|
08/01/2007 - "The combination of palatinose and oleic acid holds promise for a new approach to preventing and treating obesity and its complications."
05/01/2007 - "The Anti-Obesity Effect of the Palatinose-Based Formula Inslow is Likely due to an Increase in the Hepatic PPAR-alpha and Adipocyte PPAR-gamma Gene Expressions."
01/01/1987 - "[Effect of candy containing palatinose on human dental plaque formation]."
04/01/1997 - "Effects of frequent mouthrinses with palatinose and xylitol on dental plaque."
01/01/1984 - "Effect of frequent rinses with isomaltulose (Palatinose) solution on acid production in human dental plaque."
01/01/1985 - "Pilot studies on isomaltulose, (Palatinose), a sucrose substitute, including acid production in plaques, acid production in suspensions of dental plaque material or of Streptococcus mutans were performed, as well as studies on the effect of isomaltulose on glucan synthesis, by Strep. "
01/01/1983 - "Acid production from isomaltulose, sucrose, sorbitol, and xylitol in suspensions of human dental plaque."
|3.||Body Weight (Weight, Body)
10/01/2002 - "In several subchronic toxicity studies, the administration of large doses (up to 7.0 and 8.1 g/kg body weight/day in male and female rats, respectively) of isomaltulose, did not result in adverse effects. "
10/01/2002 - "Isomaltulose induced neither embryotoxic or teratogenic effects in rat foetuses, nor maternal toxicity at levels up to 7 g/kg body weight/day. "
03/01/1997 - "The dietary level of 10% isomaltulose was equivalent to about 7 g/kg body weight/day."
10/01/2014 - "However, the mechanism by which isomaltulose limits postprandial hyperglycemia has not been clarified. "
11/01/2005 - "Therefore, the effects of palatinose based functional food which reduces postprandial hyperglycemia and hyperinsulinemia were investigated in rats. "
08/01/2004 - "To address this problem, a novel palatinose-based enteral formula designated as MHN-01 was developed for the prevention of postprandial hyperglycemia and hyperinsulinemia. "
04/01/2007 - "Recently, we investigated the effects of a novel palatinose based enteral formula (MHN-01) in suppressing post-prandial hyperglycemia and improving lipid metabolism in experimental animals and perioperative management of patients with esophageal cancer complicated by diabetes mellitus. "
10/01/2014 - "Ingestion of slowly absorbed isomaltulose attenuates postprandial hyperglycemia by reducing oral glucose appearance, inhibiting endogenous glucose production (EGP), and increasing SGU compared with ingestion of rapidly absorbed sucrose in patients with T2DM. "
|5.||Dental Caries (White Spot)
08/01/1983 - "Cariostatic effect of palatinose on experimental dental caries in rats."
01/01/1983 - "mutans 6715 and fed a diet containing 56% palatinose did not develop significant dental caries. "
01/01/1983 - "Non-cariogenicity of the disaccharide palatinose in experimental dental caries of rats."
05/27/2008 - "The Food and Drug Administration (FDA) is adopting as a final rule, without change, the provisions of the interim final rule that amended the regulation authorizing a health claim on noncariogenic carbohydrate sweeteners and dental caries, i.e., tooth decay, to include isomaltulose as a substance eligible for the health claim. "
08/01/1983 - "Replacement of half of the sucrose content of diet #2000 with palatinose induced dental caries; however, the caries score was significantly lower than that induced by diet #2000. "
|1.||Oleic Acid (Oleate)
|9.||Sweetening Agents (Sweeteners)